GlassScriptPhysician profile
Joshua M Payne
NPI 1710243399
$7,995.73
in general payments reported to CMS, 2019-2025
24 companies · $297 in 2025
The $297 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,392 · 2020: $2,043 · 2021: $773 · 2022: $754 · 2023: $393 · 2024: $344 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,034.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,034.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $2,671.76 | 2019-2025 | |
| Arthrex, INC. | $2,268.02 | 2019 | |
| Acumed LLC | $944.32 | 2020-2022 | |
| Stryker Corporation | $564.06 | 2019-2024 | Blueprint Patient Specific Instrumentation |
| Depuy Synthes Sales INC. | $353.70 | 2019-2025 | Na, Va-Lcp |
| Goode Surgical INC | $249.02 | 2023 | |
| Medical Device Business Services, INC. | $221.02 | 2022-2024 | Vistaseal, Inhance |
| Zimmer Biomet Holdings, INC. | $147.62 | 2022 | |
| Smith+Nephew, INC. | $103.72 | 2019-2022 | |
| Biocomposites INC | $64.72 | 2019 | |
| Abiomed | $53.29 | 2025 | |
| Heron Therapeutics, INC. | $50.35 | 2021 | |
| Pacira Therapeutics, INC. | $45.24 | 2020 | |
| Innovation Technologies INC | $34.75 | 2023 | Irrisept |
| Sanara Medtech INC. | $33.33 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $31.56 | 2022-2024 | Maci |
| Ossur Americas, INC. | $29.45 | 2024 | |
| Orthofix Medical, INC. | $29.18 | 2020-2024 | Physio-Stim |
| Bioventus LLC | $22.15 | 2021 | |
| Axogen | $20.08 | 2025 | |
| Ferring Pharmaceuticals INC. | $16.70 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $14.53 | 2019 | |
| La Jolla Pharmaceutical Company | $14.10 | 2024 | Giapreza |
| Acell, INC. | $13.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Payne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.